Pharmadrug Inc (CSE: PHRX) has received approval for its majority owned joint venture, Sairiyo Therapeutics, to process with a Phase 1 clinical study...

Radiopharm Theranostics has secured the services of United States-based Dr Dimitris Voliotis as its new chief medical officer in a bid to advance the...

Satellos Biosciences (TSX:MSCL) reveals it has received approval to begin a Phase 1 clinical trial in Australia for SAT-3247.

The majority of cancer patients involved in a landmark Perth clinical trial remain in remission years later after a breakthrough treatment that...

Discover how belzutifan is redefining the treatment of advanced renal cell carcinoma, the most common type of kidney cancer, with its promising...

HANGZHOU, China, Aug. 15, 2024. Vimgreen Pharmaceuticals, a science-driven pharmaceutical company focused on the modulation of adenosine signaling,...

Indian Council of Medical Research (ICMR) and Panacea Biotec declared the start of Phase III clinical trial for India's first dengue vaccine.

CAMBRIDGE, Mass., Aug. 13, 2024. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic...

The Astana Times provides news and information from Kazakhstan and around the world.

Researchers hope the jab will bolster a person’s immune response to cancer while leaving healthy cells untouched.